Evidence map›Paper›PMID 42579196›Full record

ArticleBiotechnology letters2026

Impact of acetaminophen on the growth kinetics and metabolite production of probiotic lactic acid bacteria.

Abel Gutierrez-Vilchis, Yocanxóchitl Perfecto-Avalos, Andrea Navarro-Torres, Celia Gonzalez-Castillo, Juan Armendariz-Borunda, Alejandro Garcia-Gonzalez

Abstract read
In one paragraph

Article in Biotechnology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Abel Gutierrez-VilchisTecnologico de Monterrey, School of Medicine and Health Sciences, Av. General Ramon Corona 2514, Nuevo Mexico, 45138, Zapopan, Jalisco, Mexico.
Yocanxóchitl Perfecto-AvalosTecnologico de Monterrey, School of Engineering and Sciences, Av. General Ramon Corona 2514, Nuevo Mexico, 45138, Zapopan, Jalisco, Mexico.
Andrea Navarro-TorresBroad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.
Celia Gonzalez-CastilloTecnologico de Monterrey, School of Medicine and Health Sciences, Av. General Ramon Corona 2514, Nuevo Mexico, 45138, Zapopan, Jalisco, Mexico.
Juan Armendariz-BorundaTecnologico de Monterrey, School of Medicine and Health Sciences, Av. General Ramon Corona 2514, Nuevo Mexico, 45138, Zapopan, Jalisco, Mexico.
Alejandro Garcia-GonzalezTecnologico de Monterrey, School of Medicine and Health Sciences, Av. General Ramon Corona 2514, Nuevo Mexico, 45138, Zapopan, Jalisco, Mexico. alexgargo@tec.mx.

Funding

Tecnologico de Monterrey IJUT070-23TE88002
6 · The paper itself

Abstract

Bacterial interactions within the human gut microbiota are dynamic and closely linked to host health. These interactions are time-dependent and can be modulated by probiotic bacteria through metabolite production, environmental modification such as pH changes, and niche occupation. However, commonly used human-targeted drugs may alter these microbial dynamics. This study evaluated the effect of acetaminophen, a widely used over-the-counter drug, on the growth dynamics of a probiotic lactic acid bacterium within synthetic gut microbiota communities. The growth of Lactococcus lactis subsp. lactis was analyzed in monoculture and in co-culture with the commensal species Clostridium butyricum using 2 mL batch microbioreactors. Biomass accumulation was monitored until stationary phase, while acetaminophen and lactic acid concentrations were quantified by LC-MS. Growth kinetics were characterized using four parameters: carrying capacity, biomass accumulation (AUC), maximum growth rate (

Indexed as

AcetaminophenClostridium butyricumLactobacillalesLactococcus lactisProbioticsBiomassBioreactorsChromatography, LiquidCoculture TechniquesKineticsLactic AcidAcetaminophenLactic AcidAcetaminophenCommensalHuman gut microbiotaProbioticSynthetic community

Identifiers

PMID42579196
PMCPMC13461652

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.